Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction

Abstract

Background:

The determination of cardiac troponin is essential for diagnosing myocardial infarction. A troponin I assay has recently been developed that provides the highest analytical sensitivity to date.

Methods:

The analysis included 1560 patients with chest pain, of whom 1098 were diagnosed with non-coronary chest pain, 189 with unstable angina pectoris and 273 with non-ST-segment elevation myocardial infarction. The troponin I concentration was determined on admission (0 hours) and 3 hours later. The diagnostic algorithm incorporated troponin I elevation above the gender-specific 99th percentile as well as predefined relative or absolute 3-hour changes in the troponin I concentration (delta).

Results:

The diagnostic criterion of troponin I above the 99th percentile resulted in a negative predictive value of 98.0% and 98.2% in men and women, respectively. For rule-in of non-ST-segment elevation myocardial infarction, the use of absolute deltas yielded higher positive predictive values and sensitivities compared to relative deltas. With detection rates of about 85% and 82% in men and women, respectively, non-ST-segment elevation myocardial infarction was diagnosed with a positive predictive value close to 84% in men and 80% in women.

Conclusions:

The investigational troponin I assay provides an excellent non-ST-segment elevation myocardial infarction rule out. With gender-specific differences, the application of absolute changes in troponin concentration was superior to relative changes to rule in patients with non-ST-segment elevation myocardial infarction.

Keywords

Non-ST-segment elevation myocardial infarction cardiac troponin high-sensitivity acute myocardial infarction diagnostic performance gender-specific

Get full access to this article

View all access options for this article.

References

Thygesen

Alpert

Jaffe

. Third universal definition of myocardial infarction. Circulation 2012; 126(16): 2020–2035.

Keller

Münzel

Blankenberg

. Making it more sensitive: the new era of troponin use. Circulation 2011; 123(13): 1361–1363.

Keller

Zeller

Peetz

. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361(9): 868–877.

Reichlin

Hochholzer

Bassetti

. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361(9): 858–867.

Giannitsis

Becker

Kurz

. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010; 56(4): 642–650.

Keller

Zeller

Ojeda

. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA J Am Med Assoc 2011; 306(24): 2684–2693.

Apple

Ler

Murakami

. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012; 58(11): 1574–1581.

Bonaca

Ruff

Kosowsky

. Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study. Eur Heart J Acute Cardiovasc Care 2013; 2(3): 195–202.

Keller

Tzikas

Zeller

. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010; 55(19): 2096–2106.

10.

Thygesen

Alpert

White

. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007; 116(22): 2634–2653.

11.

Ambrose

Winters

Stern

. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5(3): 609–616.

12.

Keller

Ojeda

Zeller

. Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay. Int J Cardiol 2013; 167(4): 1423–1429.

13.

AHB

Fukushima

Puskas

. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem 2006; 52(11): 2157–2159.

14.

AHB

Todd

. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009; 55(1): 52–58.

15.

Todd

Freese

. Ultrasensitive flow-based immunoassays using single-molecule counting. Clin Chem 2007; 53(11): 1990–1995.

16.

Bonaca

O’Malley

Murphy

. Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: analysis from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care 2014; 4(5): 431–440.

17.

Zeller

Ojeda

Brunner

. High-sensitivity cardiac troponin I in the general population – defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med CCLM FESCC 2014; 53(5): 699–706.

18.

Reiter

Twerenbold

Reichlin

. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 2012; 33(8): 988–997.

19.

Biener

Mueller

Vafaie

. Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population. Int J Cardiol 2013; 167(4): 1134–1140.

20.

Mueller

Biener

Vafaie

. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012; 58(1): 209–218.

21.

Reichlin

Irfan

Twerenbold

. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011; 124(2): 136–145.

22.

Apple

Smith

Pearce

. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay. Clin Biochem 2012; 45(10–11): 711–713.